Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3953711 Title: DOSAGE IMMUNOLOGIQUE D'ÉCOULEMENT LATÉRAL POUR MESURER L'INHIBITEUR FONCTIONNEL DE C1-ESTERASE (C1-INH) DANS DES ÉCHANTILLONS DE PLASMA

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
207228966
WO application number:
US2020027406
Type:
European patent granted for BE
Status:
Open
Publication number:
3953711
WO publication number:
WO2020210446
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
26/03/2025
Link to UPP Register:
European Patent Register
Unitary Effect Status:
Unitary Effect Request Received
Unitary Effect Acceptance Decision Date:
Unitary Effect Date:
Unitary Effect Registration Date:
Unitary Effect Rejection Decision Date:
Re-establishment of Rights (EPO level) Filing Date:
Re-establishment of rights EPO Decision:
Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Explanatory Text UE:
Date of filing of the action at the UPC:
Action:
Date of decision given by the UPC:
Decision given by the UPC:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC number:
Date of appeal on a decision:
Decision after appeal:
Date of decision on an appeal:
Date of legal effect of the lapse:
Kind of lapse:
Date of Revocation (UP level):
Date of request on revocation:
Kind of revocation:
Decision on revocation request:
Reason for request for re-establishment of rights:

Dates

Filing date:
09/04/2020
Grant date:
26/02/2025
EP publication date:
16/02/2022
WO publication date:
15/10/2020
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/02/2025
EP B1 publication date:
26/02/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
09/04/2040

Applicant

Name:
Takeda Pharmaceutical Company Limited
Legal Form:
From:
26/02/2025
Address:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi,, Osaka 541-0045, Japan (JP)
To:

Inventor

1

Name:
CHOCKALINGAM, Priya, Sethu
Legal Form:
Address:
Sudbury, MA 01776, United States (US)

2

Name:
ZHOU, Zhiwei
Legal Form:
Address:
Boston, MA 02132, United States (US)

Priority

1

Priority patent number:
201962930615 P
Priority date:
05/11/2019
Priority country:
United States (US)

2

Priority patent number:
201962833235 P
Priority date:
12/04/2019
Priority country:
United States (US)

Classification

IPC or IDT classification:
G01N 33/573; G01N 33/543; G01N 33/558;

Publication

European Patent Bulletin

1

Issue number:
202509
Publication date:
26/02/2025
Description:
Grant (B1)

2

Issue number:
202514
Publication date:
02/04/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202518
Publication date:
30/04/2025
Description:
Unitary Effect Request Receipt

Annual fee

Annual fee(s) Due Date:
31/10/2025
Annual fee number:
6
Annual fee amount:
95 Euro
Penalty fee amount:
85 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type